Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen E Jardine

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|November 27, 2013
SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancerKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|November 8, 2014
Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Experimental Cell Research|July 31, 2018
Modulating SIRT1 activity variously affects thymic lymphoma development in miceKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
The Journal of Clinical Investigation|September 11, 2018
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockadeJoy Hsu, Jonathan J Hodgins, Malvika Marathe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|November 27, 2013
SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancerKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Plos One|November 8, 2014
Modulation of tumorigenesis by dietary intervention is not mediated by SIRT1 catalytic activityKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
Experimental Cell Research|July 31, 2018
Modulating SIRT1 activity variously affects thymic lymphoma development in miceKatherine V Clark-Knowles, Danielle Dewar-Darch, Karen E Jardine, et al.
The Journal of Clinical Investigation|September 11, 2018
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockadeJoy Hsu, Jonathan J Hodgins, Malvika Marathe, et al.
Pageof 1